Early results showed enrichment in the loss-of-function variants in 13 human loci involved in type I interferon (IFN)-mediated immunity to influenza infection in approximately 3.5% of previously healthy individuals facing severe disease [50]. This evidence concerns the gene IFNA1 and influenza.